Protective Effects of Benidipine on Arachidonic Acid-Induced Acute Cerebral Ischemia in Rats

The Japanese Journal of Pharmacology

Volumn 59, Issue 1, 1992, Pages 15-22

  Shirakura, Shiro ^a   Sano, Jun Ichi ^a   Karasawa, Akira ^a   Kubo, Kazuhiro ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Arachidonic acid; Benidipine; Cerebral edema; Cerebral ischemia (acute); Nicardipine

Indexed keywords

3 [4 (3 PYRIDYLMETHYL)PHENYL]METHACRYLIC ACID; ARACHIDONIC ACID; BENIDIPINE; CALCIUM ANTAGONIST; DOCEBENONE; EVANS BLUE; INDOMETACIN; LIPOXYGENASE INHIBITOR; NICARDIPINE; PROSTAGLANDIN SYNTHASE INHIBITOR; SILVER NITRATE; TICLOPIDINE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRAVASATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOGENESIS;

ANIMAL; ARACHIDONIC ACID; BENZOQUINONES; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CEREBRAL INFARCTION; DIHYDROPYRIDINES; EVANS BLUE; LIPOXYGENASE INHIBITORS; MALE; METHACRYLATES; NICARDIPINE; RATS; RATS, INBRED STRAINS; THROMBOXANE-A SYNTHASE; TICLOPIDINE;

EID: 0026752309     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.59.15     Document Type: Article

References (37)

1. Hadani, M., Young. W. and Flamm, E.S.: Nicardipine reduces calcium accumulation and electlyte derangements in regional cerebral ischemia in rats. Stroke 19, 1125-1132 (1988)
2. Grotta, J.C., Pettigrew, I.C., Rosenbaum, C, Reid, C, Rhoades, H. and McCandless, D.: Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke 19, 447-454 (1988)
3. Fujisawa, A., Matsumoto, M., Ueda, H., Wanaka, A., Yoneda, S., Kimura, K. and Kamada, T.: The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia. Stroke 17, 748-752 (1986)
4. Nishikibe, M.: Effects of the calcium entry blocker NB-818 on cerebral blood flow unilateral carotid occlusion in the Mongolian gerbil. J. Pharmacol. Exp. Ther. 246, 719-725 (1988)
5. Gelmers, HJ.: Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke. Am. J. Cardiol. 55, 144B-148B (1985)
6. Furlow, T.W. and Bass, N.H.: Stroke in rats produced carotid injection of sodium arachidonate. Science 187, 658-660 (1975)
7. Memezawa, H., Katayama, Y., Sugimoto, S., Inamura, K., Shimizu, J., Soeda, T. et al.: Arachidonic acid-induced brain ischemia: Different severity between stroke-resistant spontaneously hypertensive rats and Wistar-Kyoto rats. J. Hypertens. 4, S421-S424(1986)
8. Fujimoto, T., Suzuki, H., Tanoue, K., Fukushima. Y. and Yamazaki, H.: Cerebrovascular injuries induced by activation of platelet in vivo. Stroke 16, 245-250 (1985)
9. Furlow, T.W. and Bass, N.H.: Arachidonate-induced cerebrovascular occlusion in the rat. Neurology 26, 297 - 304 (1976)
10. Fujimoto, T., Suzuki, H., Tanoue, K., Fukusima, Y. and Yamazaki, H.: Autoradiographic observation of platelets in cerebrovascular injuries induced by arachidonic acid and its prevention by ticlopidine. Thromb. Haemost. 60, 319-323 (1988)
11. Watanabe, K., Nakasc, H. and Kimura, Y.: Effect of cilosta-zol on experimental cerebral infarction in rabbits. Arzneimittelforschung 36, 1022-1024 (1986)
12. Kubo, K., Ikeda, J., Shiozaki, S., Shuto, K., Oka, T. and Nakamizo, N.: Effects of flunarizine, a calcium antagonist on a variety of experimental cerebral ischemia models. Japan. J. Pharmacol. 40, Supp. 259P (1986)
13. Karasawa, A. and Kubo, K.: Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihy-dropyridine derivative, in isolated canine coronary arteries. Japan. J. Pharmacol. 47, 35-44 (1988)
14. Yamada, K., Yasui, S., Kishida, H., Hicjima, K., Murakami. E., Takekoshi, N. et al.: Clinical evaluation of benidipine hydrochloride (KW-3049) on angina pectoris. -A double-blind comparative study with nifedipineö. Ther. Res. 11, 1637-1656 (1990) (Abs. in English)
15. Fuji, Y., Suzuki, H., Katsuyama, H., Nakajima, S. and Saruta. T.: Hormonal and renal responses to oral once-daily calcium entry blocker in normotensive and hypertensive persons. J. Cardiovasc. Pharmacol. 11. 438-443 (1988)
16. Zimmermann, R., Zeltsch, C. and Lange, D.: Estimation of thrombus formation by labelling of platelets, red cells and fibrinogen in experimental thrombosis. Thromb. Res. 16, 147-158 (1979)
17. Feuerstein, N. and Ramwell, P.W.: OKY-1581, a potential selective thromboxane synthetase inhibitor. Eur. J. Pharmacol. 69, 533-534 (1981)
18. Yoshimoto, T., Yokoyama, C. and Ochi, K.: 2,3,5-Tri-methyl-6-(12-hydroxy-5,10-dodecanyl)-l,4-benzoquinone (AA-861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim. Biophys. Acta 713, 470-473 (1982)
19. Aiken, J.W., Shebuski, R.J., Miller, O.V. and Gorman, R.R.: Endogenous prostacyclin contribution to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis. J. Pharmacol. Exp. Ther. 219, 299-308 (1981)
20. Bando, Y., Hatanaka, S., Ohbayashi, S. and Irino, O.: A quantitative measurement of the cerebral infarction focus induced by arachidonate infusion and the relationship between measured values and stroke signs. Folia Pharmacol. Japon. 92, 193-200 (1988) (Abs. in English)
21. Hiraku, S., Taniguchi, K., Wakitani, K., Omawari, N., Kira, H., Miyamoto, T. et al.: Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(lH-imidazolylmethyl)-phenyl]-2-propenoic acid (OKY-046). Japan. J. Pharmacol. 41,393-401 (1986)
22. Minno, G.D., Cerbone, A.M., Mattioli, P.L., Turco, S., Iovine, C. and Maneini, M.: Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J. Clin. Invest. 75, 323-338 (1985)
23. Hamberg, M., Svensson, J. and Samuelsson, B.: Thromboxane, a new group of biologically active compounds derived from Prostaglandine endoperoxides. Proc. Natl. Acad. Sci. U.S.A. 72, 2994-2998 (1975)
24. Lefer, A.M., Ogletree, M.L., Smith, J.B., Silver, M.J., Nicolaou, K.C., Barnette, W.E. and Gasic, G.P.: Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 200, 52-54 (1978)
25. Ogletree, M.L., Lefer, A.M., Smith, J.B. and Nicolaou, K.C.: Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur. J. Pharmacol. 56, 95- 103 (1975)
26. Araki, H. and Lefer, A.M.: Cytoprotective action of prostacyclin during hypoxia in the isolated perfused cat liver. Am. J. Physiol. 238, H176-H181 (1980)
27. Minamisawa, H., Terashi, A., Katayama, Y., Kanda, Y., Shimizu, J., Shiratori, T. et al.: Brain eicosanoid levels in spontaneously hypertensive rats after ischemia with reperfusion: Leukotriene C4 as a possible cause of cerebral edema. Stroke 19, 372-377 (1988)
28. Dempsey, R.J., Roy, M.W., Cowen, D.E. and Maley, M.E.: Lipoxygenase metabolites of araehidonic acid and the development of ischaemic cerebral oedema. Neurol. Res. 8, 53-56(1986)
29. Hladovec, J. and De Clerck, F.: Protection by flunarizine against endothelial cell injury in vivo. Angiology 32, 448-462 (1981)
30. Karasawa, A., Rochester, J.A., Ma, X.-L. and Lefer, A.M.: Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion. Cire. Shock 33, 135- 141 (1991)
31. Chan, P.H. and Fishman, R.A.: The role of araehidonic acid in vasogenic brain edema. Fed. Proc. 43, 210-213 (1984)
32. Chan, P.H., Fishman, R.A., Caronna, J., Schmidley, J.W., Prioleau, G. and Lee, J.: Induction of brain edema following intracerebral injection of araehidonic acid. Ann. Neurol. 13, 625-632(1983)
33. Speetor, A.A. and Hoak, J.C.: Fatty acids, platelets and microcirculatory obstruction. Science 190, 490-491 (1975)
34. Schanne, F.A.X., Kane, A.B., Young, E.E. and Farber, J.L.: Calcium dependence of toxicity of cell death: A final common pathway. Science 206, 700-702 (1979)
35. Farber, J.L.: The role of calcium in cell death. Life Sci. 29, 1289-1295 (1981)
36. Karasawa, A. and Kubo, K.: Inhibitory effect of KW-3049, a new 1,4-dihydropyridine calcium antagonist, on the reduction of myocardial creatine kinase activity and high energy phosphate content in rats subjected to coronary artery ligation. J. Pharmacobiodyn. 11, 722-729 (1988)
37. Karasawa, A. and Kubo, K.: Protection by benidipine hydrochloride (KW-3049), a calcium antagonist, of ischemic kidney in rats via inhibitions of Ca-overload, ATP-decline and lipid peroxidation. Japan. J. Pharmacol. 52, 553-562 (1990)